Wooree BioLtd Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Gil-Soo Park
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
No updates
Recent updates
Does Wooree BioLtd (KOSDAQ:082850) Have A Healthy Balance Sheet?
Dec 16Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%
Oct 23Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%
Sep 07Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns
Aug 30Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?
Aug 10Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up
Jul 19Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising
May 25These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well
May 03Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too
Apr 26Should You Invest In Wooree BioLtd (KOSDAQ:082850)?
Feb 28Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly
Feb 01Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 12Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain
Dec 21Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative
Nov 29CEO
Gil-Soo Park (61 yo)
no data
Tenure
Mr. Park, Gil-Soo has been Senior Managing Director of Wooree Lighting Co., Ltd. since November 2011. Mr. Park serves as a Director of IM Tech Inc. He graduated from Yonsei University, majored in Business...
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 16:11 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wooree Bio Co.,Ltd is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jonathan Rhee | Citigroup Inc |
Sang Hyeon Park | iM Securities |
Jong Woo Yoo | Korea Investment & Securities Co., Ltd. |